On Tuesday, Mind Medicine Inc (NASDAQ: MNMD) was 3.75% up from the session before settling in for the closing price of $7.2. A 52-week range for MNMD has been $4.70 – $10.44.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 12.11%. When this article was written, the company’s average yearly earnings per share was at 5.67%. With a float of $72.87 million, this company’s outstanding shares have now reached $75.51 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mind Medicine Inc stocks. The insider ownership of Mind Medicine Inc is 3.55%, while institutional ownership is 54.03%. The most recent insider transaction that took place on Jun 25 ’25, was worth 78,139. In this transaction Chief Legal Officer of this company sold 11,491 shares at a rate of $6.80, taking the stock ownership to the 305,130 shares. Before that another transaction happened on Jun 25 ’25, when Company’s Chief Medical Officer sold 7,848 for $6.80, making the entire transaction worth $53,366. This insider now owns 438,329 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 5.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.97% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
You can see what Mind Medicine Inc (MNMD) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 7.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.04, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.55 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
The latest stats from [Mind Medicine Inc, MNMD] show that its last 5-days average volume of 1.07 million was inferior to 1.57 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 88.62%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 48.29%, which indicates a significant decrease from 97.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.45 in the past 14 days, which was lower than the 0.49 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.96, while its 200-day Moving Average is $6.84. Now, the first resistance to watch is $7.56. This is followed by the second major resistance level at $7.65. The third major resistance level sits at $7.80. If the price goes on to break the first support level at $7.32, it is likely to go to the next support level at $7.17. The third support level lies at $7.08 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
There are 75,553K outstanding shares of the company, which has a market capitalization of 564.38 million. As of now, sales total 0 K while income totals -108,680 K. Its latest quarter income was 0 K while its last quarter net income were -23,350 K.
